High caffeine levels associated with weight loss and type 2 diabetes risk: BMJ

Published Date: 17 Mar 2023

UK: A recent study published in BMJ Medicine found that more caffeine in the blood can reduce the risk of type 2 diabetes and obesity. more...

Read Full News

Latest News

More Children Under 12 in US Are Being Prescribed Weight-loss Drugs, Study Finds

Prescriptions for GLP-1 weight-loss drugs among children under 12 in the U.S. have risen more than 300-fold since 2019 as doctors ⁠seek new, effective treatments for younger...

Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity

Novo Nordisk said on Monday it had halted two ⁠additional trials of its experimental cardiovascular drug ziltivekimab, further denting the Danish drugmaker's ⁠efforts to...

MicroRNA Panel May Predict Early Liver Metastasis in PDAC

A machine learning model using 7 exosomal microRNAs can identify patients with pancreatic ductal adenocarcinoma at risk for early liver metastasis.

Can a Smoothie Boost GLP-1 Naturally?

Certain foods and products can support individuals taking GLP-1s for weight management, but they can’t boost GLP-1 production or be used rather than medications.

Metyrapone Linked to Improved Quality of Life in Cushing

Metyrapone is associated with progressive improvements in quality of life among patients with Cushing syndrome, with recovery timing and patterns varying across symptom domains.

How to Help Manage Depression After GLP-1 Weight Regain

Offer realistic expectations when medication use ends and provide the tools to remain on track.

Todays Updates

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

The less-intensive drug combination outperforms standard induction chemotherapy in fit patients with acute myeloid leukemia.

Todays Updates

A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

The less-intensive drug combination outperforms standard induction chemotherapy in fit patients with acute myeloid leukemia.

Latest News

Prescriptions for GLP-1 weight-loss drugs among children under 12 in the U.S. have risen more than 300-fold since 2019 as doctors ⁠seek new, effective treatments for younger...

Novo Nordisk said on Monday it had halted two ⁠additional trials of its experimental cardiovascular drug ziltivekimab, further denting the Danish drugmaker's ⁠efforts to...

A machine learning model using 7 exosomal microRNAs can identify patients with pancreatic ductal adenocarcinoma at risk for early liver metastasis.

Certain foods and products can support individuals taking GLP-1s for weight management, but they can’t boost GLP-1 production or be used rather than medications.

Metyrapone is associated with progressive improvements in quality of life among patients with Cushing syndrome, with recovery timing and patterns varying across symptom domains.

Offer realistic expectations when medication use ends and provide the tools to remain on track.

News All Time

Too Weak, Too Strict: India's Food Warning Labels Draw Fire From All Sides

The Indian government is facing fierce opposition on proposed food warning labels from both health experts and food giants - activists say many items will escape scrutiny...

Early Childhood Obesity Linked to Adolescent Obesity Risk

Obesity during early childhood is strongly linked to obesity by adolescence, whereas overweight carries a far smaller risk for progression — even after a recent BMI rise from normal weight.

Hims & Hers Offers GLP-1s, Men's Health Treatments in Australia

Telehealth company Hims & Hers has begun offering GLP-1 weight-loss drugs and other treatments ⁠to men in Australia as it continues to expand its international business.

600,000 Seniors Have Signed Up for Obesity Drugs Under New Medicare Program

U.S. Centers for ⁠Medicare and Medicaid Services Administrator ⁠Dr. Mehmet Oz said ⁠on Monday ‌that 600,000 seniors have signed up to receive GLP-1 weight ‌loss medications...

GLP-1 Weight Loss Drugs Effective Even At Low Starter Doses

People taking popular GLP-1 obesity drugs who remain on low starter doses will lose some weight but may still experience side effects, although significantly less nausea...

Time-Restricted Eating Helps Sustain Weight Loss

New research shows an 8-hour eating window can help sustain weight loss for a year. Meal timing, alongside diet quality and exercise may be a useful, personalized tool.

Novo Nordisk Launches Wegovy Weight-Loss Pill in Germany

Novo Nordisk has launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on Tuesday.

Contraceptives Affect Steroid Profiles in Females With CAH

Combined oral contraceptives reduce plasma and urinary androgen levels and increase total cortisol levels in adolescent and young females with congenital adrenal hyperplasia.

Thyroid Hormone Receptor Beta Agonist Cuts Liver Fat in MASH

A selective thyroid hormone receptor beta agonist demonstrates dose-dependent reductions in hepatic fat among adults with metabolic dysfunction-associated steatohepatitis in a phase 2 trial.

Thyroid Shifts in Midlife Women? Blame Aging, Not Menopause

Thyroid problems in midlife women may have less to do with menopause than doctors think, and more to do with simply getting older, a new study suggests.

How Female Biology Could Solve the Mystery of Longevity

Why do women live longer than men? An evolutionary question sparks a new hypothesis that dovetails with a growing movement in longevity research.

Food Noise, Weight Stigma, and Managing Obesity

Why doesn’t food noise go quiet for everyone on GLP-1s? Why is the bias against them getting louder? And what does long-term obesity management actually look like?

Diabetes Technology Helps T1D but Also Adds Burdens

A qualitative survey finds both expected and less-appreciated hurdles with the use of insulin pumps, CGMs, and automated insulin delivery systems.

New Breathalyzer Detects When Your Body Is Burning Fat

A hand-held device that measures acetone levels in your breath — signaling ketosis — matched mass spectrometry tests for accuracy. But clinical uses may be limited for now.

Over-the-Counter Continuous Glucose Monitors: Okay for Kids?

A pediatric endocrinologist raises questions about use in youth without diabetes.

Surprising Signal for Semaglutide in Bipolar Disorder

The GLP-1 semaglutide was linked to fewer psychiatric hospitalizations in patients with bipolar disorder, raising the possibility of benefits beyond weight loss and glycemic control.